Loading...
ScienceDaily: Top Health News |
| Research advances knowledge of the battle between viruses and human cells Posted: 18 Feb 2022 12:30 PM PST In the long-term battle between a herpesvirus and its human host, a virologist and her team of students have identified some human RNA able to resist the viral takeover -- and the mechanism by which that occurs. |
| Mental speed hardly changes over a lifespan Posted: 18 Feb 2022 12:30 PM PST Mental speed -- the speed at which we can deal with issues requiring rapid decision-making -- does not change substantially over decades. Psychologists have come to this conclusion. They evaluated data from a large-scale online experiment with over a million participants. The findings of the new study suggest that the speed of cognitive information processing remains largely stable between the ages of 20 and 60, and only deteriorates at higher ages. |
| Scientists map entire human gut at single cell resolution Posted: 18 Feb 2022 12:30 PM PST Scientists have used entire human GI tracts from three organ donors to show how cell types differ across all regions of the intestines, to shed light on cellular functions, and to show gene expression differences between these cells and between individuals. |
| Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer Posted: 18 Feb 2022 08:07 AM PST Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy and chemotherapy prolongs the survival of men with metastatic, hormone-sensitive prostate cancer. |
| Researchers identify protein complex critical in helping control cell death Posted: 18 Feb 2022 07:07 AM PST A pathway critical for regulating a form of cell death known as necroptosis has been identified. The team's preclinical findings suggest that an inhibitor targeting this PPP13RG protein complex can help prevent or reduce deaths and severe tissue damage from heart attacks and other inflammation-associated diseases. |
| Nebulin no longer nebulous! Scientists obtain first high-resolution 3D image of muscle protein Posted: 18 Feb 2022 07:07 AM PST Scientists have obtained the first high-resolution 3D image of nebulin, a giant actin-binding protein that is an essential component of skeletal muscle. This discovery has brought to light the chance to better understand the role of nebulin, as its functions have remained largely nebulous due to its large size and the difficulty in extracting nebulin in a native state from muscle. The team used electron cryo-tomography to decipher the structure of nebulin in impressive detail. Their findings could lead to novel therapeutic approaches to treat muscular diseases, as genetic mutations in nebulin are accompanied by a dramatic loss in muscle force known as nemaline myopathy. |
| Gut health compromised in severe COVID-19 Posted: 18 Feb 2022 07:07 AM PST New research of samples of intestine from people who have died of COVID-19 has shown the impact of the virus on the gut immune system. |
| Treatment for Parkinson’s could now get even better Posted: 18 Feb 2022 07:07 AM PST Specialized groups of neurons within the brainstem control movement. Now researchers have found that activation of such neurons is sufficient to restore full movement function in mice with symptoms of Parkinson's Disease. The study helps clinicians to focus Deep Brain Stimulation to the right therapeutic spot and hopefully could improve treatment of motor symptoms in Parkinson's Disease. |
| Myelination determines the nerve cell power of inhibition, study finds Posted: 18 Feb 2022 07:06 AM PST Researchers shed new light on how myelin loss might underpin aberrant brain activity which have been observed in people with multiple sclerosis. The study suggests that myelination, however patchy on specific interneurons, is required to reach their full inhibitory potential. |
| Posted: 18 Feb 2022 07:06 AM PST Legionellosis or Legionnaires' disease affected more than 1 800 people in France in 2019 and caused 160 deaths. This emerging disease is caused by Legionella pneumophila, an environmental bacterium that thrives in hot water systems. Researchers have discovered a mechanism that allows Legionella pneumophila to target the immune response of the cells it infects by secreting a small regulatory RNA. This mechanism, not described before, facilitates the survival and proliferation of Legionella pneumophila during infection. The work provides precious information on the strategies used by bacteria to manipulate their host cells. |
| Posted: 18 Feb 2022 07:06 AM PST The new study from the University of Bath's School of Management reveals care from a co-worker inspires people to be supportive to their partner at home, showing that co-workers have a significant role to play in enabling couples to cope with balancing the demands of work and family life. This spiral of support has knock on benefits for creative thinking at work. |
| Antibiotics after birth affects gut microbes of babies Posted: 18 Feb 2022 05:02 AM PST Treating babies with antibiotics in the first week of life is linked with a decrease in healthy bacteria necessary amongst others to digest milk and an increase in antimicrobial resistance, research suggests. Experts say that clinicians should consider using antibiotics in a way that causes least harm to the newborns microbiome - the community of microbes that live in our body. |
| Protein structure offers clues to drug-resistance mechanism Posted: 18 Feb 2022 05:02 AM PST Chemists discovered the structure of a protein that can pump toxic molecules out of bacterial cells. Knowledge of this structure may make it possible to design drugs that could block transport proteins and help resensitize drug-resistant bacteria to existing antibiotics. |
| Analysis of DNA reveals weapons used by our immune cells to fight tuberculosis Posted: 17 Feb 2022 11:12 AM PST A study has identified a gene, KCNJ15, that is associated with helping our immune system fight tuberculosis (TB), and potentially other infectious diseases. |
| You are subscribed to email updates from Top Health News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
Loading...
Loading...
